• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SLC45A4 通过糖酵解代谢重编程参与卵巢癌的恶性进展。

SLC45A4 is involved in malignant progression of ovarian cancer through glycolytic metabolic reprogramming.

机构信息

Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China.

出版信息

Sci Rep. 2024 Oct 3;14(1):23031. doi: 10.1038/s41598-024-74249-z.

DOI:10.1038/s41598-024-74249-z
PMID:39363015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11450204/
Abstract

Tumor cells promote malignant behaviors such as proliferation, invasion, and metastasis of cancer cells through glucose metabolic reprogramming, but the role of the H-dependent sugar cotransporter SLC45A4 in regulating metabolic reprogramming in ovarian cancer (OC) remains largely unknown. This study aimed to investigate the effects of SLC45A4 silencing on the transcriptome spectrum of ovarian cancer cells (OCC), glucose uptake, lactic acid production, intracellular ATP levels, and the expression and activity of HIF-α glycolysis signaling pathway. The results showed that SLC45A4 is overexpressed in OC and its elevated expression correlates with adverse clinical outcomes in OC patients. Silencing of SLC45A4 significantly inhibited the proliferation, invasion, and metastasis of OCC by suppressing glucose uptake and glycolysis, and it also reduced the expression of HIF-α glycolysis signaling pathway in OC tissues. In vivo experiments using shRNA to knock down SLC45A4 in xenograft models in nude mice demonstrated a significant inhibition of tumor growth. These findings suggest that SLC45A4 silencing can restrain the malignant progression of OC by inhibiting glucose uptake in OCC and affecting the reprogramming of glycolytic energy metabolism, indicating that SLC45A4 may serve as a potential therapeutic target for OC intervention.

摘要

肿瘤细胞通过葡萄糖代谢重编程促进癌细胞的增殖、侵袭和转移等恶性行为,但 H+依赖型糖共转运蛋白 SLC45A4 在调节卵巢癌(OC)代谢重编程中的作用在很大程度上尚不清楚。本研究旨在探讨 SLC45A4 沉默对卵巢癌细胞(OCC)转录组谱、葡萄糖摄取、乳酸生成、细胞内 ATP 水平以及 HIF-α糖酵解信号通路表达和活性的影响。结果表明,SLC45A4 在 OC 中过度表达,其表达水平升高与 OC 患者的不良临床结局相关。沉默 SLC45A4 可通过抑制葡萄糖摄取和糖酵解显著抑制 OCC 的增殖、侵袭和转移,还可降低 OC 组织中 HIF-α糖酵解信号通路的表达。在裸鼠异种移植模型中使用 shRNA 敲低 SLC45A4 的体内实验表明,肿瘤生长受到显著抑制。这些发现表明,SLC45A4 沉默通过抑制 OCC 中的葡萄糖摄取和影响糖酵解能量代谢的重编程,可以抑制 OC 的恶性进展,提示 SLC45A4 可能成为 OC 干预的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/2a402e9cebbb/41598_2024_74249_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/8dd602eaf5ba/41598_2024_74249_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/855682b80f3f/41598_2024_74249_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/db743053b4d7/41598_2024_74249_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/28a216976d00/41598_2024_74249_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/034cf7228db9/41598_2024_74249_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/2a402e9cebbb/41598_2024_74249_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/8dd602eaf5ba/41598_2024_74249_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/855682b80f3f/41598_2024_74249_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/db743053b4d7/41598_2024_74249_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/28a216976d00/41598_2024_74249_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/034cf7228db9/41598_2024_74249_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea2b/11450204/2a402e9cebbb/41598_2024_74249_Fig6_HTML.jpg

相似文献

1
SLC45A4 is involved in malignant progression of ovarian cancer through glycolytic metabolic reprogramming.SLC45A4 通过糖酵解代谢重编程参与卵巢癌的恶性进展。
Sci Rep. 2024 Oct 3;14(1):23031. doi: 10.1038/s41598-024-74249-z.
2
TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.沉默 TRPM7 通过增强 AMPK 激活来促进 HIF-1α 降解,调节葡萄糖代谢重编程,从而抑制卵巢癌细胞生长。
J Exp Clin Cancer Res. 2022 Jan 31;41(1):44. doi: 10.1186/s13046-022-02252-1.
3
SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma.SLC45A4 促进糖酵解并防止 TP53 突变型胰腺导管腺癌中 AMPK/ULK1 诱导的自噬。
J Gene Med. 2021 Sep;23(9):e3364. doi: 10.1002/jgm.3364. Epub 2021 Jun 2.
4
SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.SIK2 通过 PI3K/AKT/HIF-1α 通路和 Drp1 介导线粒体分裂促进卵巢癌细胞糖代谢重编程。
Cancer Lett. 2020 Jan 28;469:89-101. doi: 10.1016/j.canlet.2019.10.029. Epub 2019 Oct 19.
5
MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.MIEF2 过表达通过重编程卵巢癌细胞葡萄糖代谢促进肿瘤生长和转移。
J Exp Clin Cancer Res. 2020 Dec 14;39(1):286. doi: 10.1186/s13046-020-01802-9.
6
TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis.TCEB2/HIF1A 信号轴通过增强糖酵解和血管生成促进卵巢癌细胞的化疗耐药性。
Eur J Med Res. 2024 Sep 11;29(1):456. doi: 10.1186/s40001-024-02050-9.
7
ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment.ESM1 通过在缺氧肿瘤微环境中利用 PKM2 依赖性瓦博格效应增强脂肪酸合成和血管拟态在卵巢癌中的作用。
Mol Cancer. 2024 May 8;23(1):94. doi: 10.1186/s12943-024-02009-8.
8
OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.OTUB2基因沉默通过线粒体代谢重编程促进卵巢癌发展,并且可通过抑制碳酸酐酶9(CA9)进行合成靶向治疗。
Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2315348121. doi: 10.1073/pnas.2315348121. Epub 2024 May 3.
9
BBOX1 mediates metabolic reprogramming driven by hypoxia and participates in the malignant progress of high-grade serous ovarian cancer.BBOX1 介导缺氧驱动的代谢重编程,并参与高级别浆液性卵巢癌的恶性进展。
Biochim Biophys Acta Mol Cell Res. 2024 Dec;1871(8):119830. doi: 10.1016/j.bbamcr.2024.119830. Epub 2024 Aug 23.
10
Sodium selenite inhibits cervical cancer progression via ROS-mediated suppression of glucose metabolic reprogramming.亚硒酸钠通过 ROS 介导的抑制葡萄糖代谢重编程抑制宫颈癌进展。
Life Sci. 2024 Nov 15;357:123109. doi: 10.1016/j.lfs.2024.123109. Epub 2024 Oct 9.

本文引用的文献

1
Pachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches.先天性厚甲症:引领新治疗方法的研究议程。
J Invest Dermatol. 2024 Apr;144(4):748-754. doi: 10.1016/j.jid.2023.10.030. Epub 2023 Dec 15.
2
Database mining analysis revealed the role of the putative H/sugar transporter solute carrier family 45 in skin cutaneous melanoma.数据库挖掘分析揭示了假定的 H/糖转运蛋白溶质载体家族 45 在皮肤黑色素瘤中的作用。
Channels (Austin). 2021 Dec;15(1):496-506. doi: 10.1080/19336950.2021.1956226.
3
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.
专为医学研究量身定制的基于网络的生存分析工具(KMplot):开发与应用
J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196/27633.
4
SLC45A2 protein stability and regulation of melanosome pH determine melanocyte pigmentation.SLC45A2 蛋白稳定性和黑素小体 pH 的调节决定了黑素细胞的色素沉着。
Mol Biol Cell. 2020 Nov 15;31(24):2687-2702. doi: 10.1091/mbc.E20-03-0200. Epub 2020 Sep 23.
5
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.
6
Advances and Challenges in Rational Drug Design for SLCs.SLC 类药物合理设计的进展与挑战。
Trends Pharmacol Sci. 2019 Oct;40(10):790-800. doi: 10.1016/j.tips.2019.08.006. Epub 2019 Sep 10.
7
Relevance of solute carrier family 5 transporter defects to inherited and acquired human disease.溶质载体家族 5 转运体缺陷与遗传性和获得性人类疾病的相关性。
J Appl Genet. 2019 Nov;60(3-4):305-317. doi: 10.1007/s13353-019-00502-1. Epub 2019 Jul 8.
8
Epithelial ovarian cancer.上皮性卵巢癌。
Lancet. 2019 Mar 23;393(10177):1240-1253. doi: 10.1016/S0140-6736(18)32552-2.
9
Acidosis and cancer: from mechanism to neutralization.酸中毒与癌症:从机制到中和。
Cancer Metastasis Rev. 2019 Jun;38(1-2):149-155. doi: 10.1007/s10555-019-09787-4.
10
The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose.低葡萄糖环境下,反应性降低的 PKM2 有利于胰腺癌细胞的存活。
Cell Death Dis. 2018 Jan 26;9(2):133. doi: 10.1038/s41419-017-0158-5.